[Classics with innovative potential noted. The MMW drug prize for inhalative airway therapeutics].
Füessl
H S
HS
D000287:Administration, Topical; D000318:Adrenergic beta-Agonists / Q000008:administration & dosage*; D000420:Albuterol / Q000008:administration & dosage* / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000730:Androstadienes / Q000008:administration & dosage*; D018927:Anti-Asthmatic Agents / Q000008:administration & dosage*; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D001363:Awards and Prizes; D001993:Bronchodilator Agents / Q000008:administration & dosage*; D004338:Drug Combinations; D004345:Drug Industry; D000068298:Fluticasone; D005858:Germany; D005938:Glucocorticoids; D006801:Humans; D010349:Patient Compliance; D010506:Periodicals as Topic; D012138:Respiratory Therapy; D000068299:Salmeterol Xinafoate
D000318:Adrenergic beta-Agonists; D000730:Androstadienes; D018927:Anti-Asthmatic Agents; D000893:Anti-Inflammatory Agents; D001993:Bronchodilator Agents; D004338:Drug Combinations; D005938:Glucocorticoids; D000068299:Salmeterol Xinafoate; D000068298:Fluticasone; D000420:Albuterol